Top Markets
#1 Siren Siren +33.52%
#2 Wiki Cat Wiki Cat +25.95%
#3 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +17.28%
#4 Ribbita by Virtuals Ribbita by Virtuals +17.15%
#5 PulseChain PulseChain +16.92%
#6 Velvet Velvet +16.59%
#7 Cysic Cysic +15.77%
#8 Bitway Bitway +15.75%
#9 The Grays Currency The Grays Currency +15.71%
#10 Wrapped Pulse Wrapped Pulse +15.37%
Coin of the day
Siren Siren
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Rangering i aksjer #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Aksjekurs
$0.089
Sist synkronisert: 2026-08-17
Markedsverdi
$15.36M
Endring (1 dag)
50.59%
Endring (1 år)
111.85%
Land
US
Handel Inhibitor Therapeutics, Inc. (INTI)

Kategori

Healthcare
P/B-forhold for Inhibitor Therapeutics, Inc. (INTI)
P/B-forhold per 2026 TTM: 0
Ifølge Inhibitor Therapeutics, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Inhibitor Therapeutics, Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE